Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules — Class II drug recall D-0488-2017
Terminated recall by MOORE'S COMPOUNDING PHARMACY, reported 2017-03-01, distributed in TX. Superpotent Drug and Subpotent Drug; potency failures obtained
| Recall number | D-0488-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | MOORE'S COMPOUNDING PHARMACY, Corpus Christi, TX, United States |
| Recall initiated | 2016-09-12 |
| Classified | 2017-02-21 |
| Reported by FDA | 2017-03-01 |
| Terminated | 2017-05-17 |
| Distributed | TX |
| Quantity | 90 capsules |
| Reason classes | potency |
| Expiration dates | 2017-02-18 |
Product
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
Reason for recall
Superpotent Drug and Subpotent Drug; potency failures obtained
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0488-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.